BTTX Better Therapeutics Inc

USD 0.01 0.00 0
Icon

Better Therapeutics Inc (BTTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01

0.00 (0.00)%

USD 0.57M

0.15M

N/A

N/A

Icon

BTTX

Better Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.01
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.57M

N/A

USD 0.01

Better Therapeutics Inc (BTTX) Stock Forecast

N/A

Based on the Better Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Better Therapeutics Inc is not available over the next 12 months. Better Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Better Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Better Therapeutics Inc’s stock price was USD 0.0105. Better Therapeutics Inc’s stock price has changed by -27.08% over the past week, +29.63% over the past month and -98.79% over the last year.

No recent analyst target price found for Better Therapeutics Inc
No recent average analyst rating found for Better Therapeutics Inc

Company Overview Better Therapeutics Inc

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It ...Read More

https://www.bettertx.com

548 Market Street, San Francisco, CA, United States, 94104

54

December

USD

USA

Adjusted Closing Price for Better Therapeutics Inc (BTTX)

Loading...

Unadjusted Closing Price for Better Therapeutics Inc (BTTX)

Loading...

Share Trading Volume for Better Therapeutics Inc Shares

Loading...

Compare Performance of Better Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BTTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Better Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing BTTX

Symbol Name BTTX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Better Therapeutics Inc (BTTX) Stock

Stock Target Advisor's fundamental analysis for Better Therapeutics Inc's stock is Very Bearish.

Unfortunately we do not have enough data on BTTX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BTTX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BTTX's stock to indicate if its overvalued.

The last closing price of BTTX's stock was USD 0.01.

The most recent market capitalization for BTTX is USD 0.57M.

Unfortunately we do not have enough analyst data on BTTX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Better Therapeutics Inc's stock.

As per our most recent records Better Therapeutics Inc has 54 Employees.

Better Therapeutics Inc's registered address is 548 Market Street, San Francisco, CA, United States, 94104. You can get more information about it from Better Therapeutics Inc's website at https://www.bettertx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...